Salivary Cortisol Testing Clinical Validity

Last updated: October 4, 2026 - Reviewed by Verdant Wellness Editorial Team

RD

By Gabriela Mitchell, Registered Dietitian (Linkedin)

Last Updated September 2026  ·  25 min read

10% off · weekly tips

Real science on cortisol, stress, and sleep.

Send it →

---

Table of Contents

1. What Is Salivary Cortisol and Why Does It Matter?
2. The Science Behind Free Cortisol in Saliva
3. Salivary Cortisol Clinical Validity for Cushing's Syndrome
4. Late-Night vs. Morning Testing: Timing Changes Everything
5. Salivary Cortisol for Adrenal Insufficiency
6. Salivary Cortisol vs. Serum and Urine Cortisol
7. Salivary Cortisol vs. Salivary Cortisone: A Critical Distinction
8. Immunoassay vs. LC-MS/MS: Which Method Is More Reliable?
9. What Causes False Positives and False Negatives?
10. What 2024–2025 Research Adds to the Picture
11. Practical Guidance for Clinicians and Patients
12. Frequently Asked Questions

---

Introduction

Measuring cortisol has long been central to diagnosing disorders of the hypothalamic-pituitary-adrenal (HPA) axis, from Cushing's syndrome to adrenal insufficiency. For decades, that measurement meant either a blood draw or a 24-hour urine collection—neither of which is especially comfortable or convenient. Salivary cortisol testing offered a compelling alternative: a simple, non-invasive, repeatable sample collected at home. But convenience alone does not equal clinical validity.

The deeper question—the one that endocrinologists, researchers, and patients increasingly want answered—is whether the salivary cortisol testing clinical validity holds up under real-world diagnostic pressure. Does a saliva cortisol test deliver results accurate enough to make or change clinical decisions? Under what conditions does salivary cortisol reliability hold, and where does it falter?

This post works through those questions systematically, drawing on peer-reviewed research published from foundational studies through the latest 2025 findings.

---

★★★★★ 4.8 · 1,247 reviews

Feel Calm By Bedtime. Focused By Morning.

Adaptogen-based formula. Third-party tested. Made in an FDA-registered facility. Backed by a 60-day money-back guarantee.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

What Is Salivary Cortisol and Why Does It Matter?

Cortisol is a glucocorticoid steroid hormone synthesized in the adrenal cortex in response to adrenocorticotropic hormone (ACTH) from the pituitary gland. In blood, the vast majority of cortisol—roughly 80 to 90 percent—circulates bound to corticosteroid-binding globulin (CBG) or albumin. Only the unbound fraction is biologically active.

Saliva represents a biological window into that unbound, biologically active fraction. Free cortisol saliva concentrations reflect serum free cortisol with reasonable fidelity because cortisol passively diffuses across salivary gland cells through a concentration-dependent mechanism. This means that changes in CBG levels—which occur during pregnancy, oral contraceptive use, or liver disease—do not distort salivary cortisol measurements the way they can distort total serum cortisol.

This is a meaningful clinical advantage. A patient on oral contraceptives will typically show a falsely elevated total serum cortisol due to elevated CBG, which can complicate the interpretation of dynamic testing. The same patient's salivary cortisol reading reflects her actual free cortisol exposure, making salivary cortisol clinical use particularly relevant in populations where CBG fluctuations are common.

The salivary cortisol biomarker is also a practical one. Saliva samples can be collected at home, at specific times of day, without a healthcare professional present. This enables sampling protocols—particularly late-night collection—that would be logistically impossible or cost-prohibitive with blood draws alone.

The Science Behind Free Cortisol in Saliva

Understanding the physiology helps explain both the strengths and the limitations of saliva cortisol research.

Cortisol enters saliva primarily by passive diffusion across the acinar cells of the salivary glands. Because this process is passive and concentration-dependent, salivary cortisol concentrations track serum free cortisol quite closely under most conditions. The correlation between serum free cortisol and salivary cortisol has been demonstrated across multiple study designs and populations.

However, saliva is not a perfect ultrafiltrate of serum. Several complicating factors exist:

Local metabolism in salivary glands. The enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) is expressed in salivary glands and converts cortisol to cortisone. This means salivary glands are not passive transport surfaces—they actively metabolize a portion of the cortisol that enters them. As a result, salivary cortisone concentrations can actually exceed salivary cortisol concentrations in many individuals, and the ratio between the two carries diagnostic information in its own right.

Salivary flow rate. Stimulated saliva (produced by chewing or the presence of a collection device) has different composition than unstimulated saliva. Most validated protocols use passive drool or specific cotton roll devices to collect unstimulated or minimally stimulated samples. Using acidified citric acid swabs—a common method—can alter local gland activity and affect cortisol-to-cortisone ratios.

Contamination. Blood contamination from gum disease, vigorous brushing, or mucosal injury can introduce serum cortisol directly into the sample, creating a falsely elevated reading. This is one of the most common sources of error in cortisol saliva accuracy research.

Collection device matrix effects. Different collection devices (Salivette, Sarstedt, passive drool tubes) interact differently with immunoassay reagents. Some polypropylene-based devices show interference with certain antibodies, which matters when comparing results across laboratories or studies.

Salivary Cortisol Clinical Validity for Cushing's Syndrome

If there is a single condition where salivary cortisol validity has been most thoroughly studied, it is Cushing's syndrome. The late-night salivary cortisol (LNSC) test exploits a fundamental feature of Cushing's pathophysiology: the loss of the normal circadian nadir. In healthy individuals, cortisol reaches its lowest point between midnight and 2 a.m. In patients with Cushing's syndrome, autonomous cortisol production eliminates this trough.

The Foundational Evidence

One of the most cited early studies in this field established that a bedtime salivary cortisol cutoff greater than 550 ng/dL (15.2 nmol/L) identified 93% of patients with Cushing's syndrome while excluding all individuals without the disorder in that cohort. Published in 2002, this finding helped establish LNSC as a front-line screening tool and gave the field a robust starting reference point for sensitivity-specificity trade-offs.

This level of performance placed LNSC testing alongside—and in some respects ahead of—the 24-hour urinary free cortisol (UFC) and the 1-mg overnight dexamethasone suppression test (ONDST) as recommended first-line tests in major endocrine society guidelines.

Sensitivity Varies by Cushing's Subtype

More nuanced data emerged as larger cohorts and better assay methods became available. A retrospective study published in 2020 revealed an important limitation: late-night salivary cortisol measured by enzyme immunoassay with fluorescence detection (EIA-F) showed 97.5% sensitivity for neoplastic hypercortisolism—essentially meaning it almost never missed a cortisol-secreting tumor. However, that same method demonstrated only 31.3% sensitivity for ACTH-independent Cushing's syndrome, a significantly lower-prevalence but clinically distinct subtype.

The 2020 study also found that a single elevated LNSC result had poor specificity and poor positive predictive value—a reminder that a single positive result should not be used as the sole basis for diagnosis. The Endocrine Society guidelines already recommend confirming abnormal results with at least two separate measurements, and this data reinforces why that recommendation exists.

What 2025 Added

More recently, the focus has partly shifted toward salivary cortisone rather than cortisol alone for Cushing's evaluation. A 2025 study examining morning salivary cortisone versus serum cortisol in suspected Cushing's syndrome found 100% sensitivity for ONDST-based evaluation, with reasonable specificity. This opens the possibility that morning salivary cortisone combined with—or as an alternative to—the ONDST could serve as a first-line test, particularly in outpatient settings where venipuncture is a barrier.

A 2025 endocrine abstract validation also confirmed late-night salivary cortisol and cortisone as high-accuracy markers for Cushing's syndrome, noting that the addition of salivary cortisone measurement strengthened the diagnostic signal beyond cortisol alone.

The cortisol saliva test for Cushing's syndrome, then, is not a single static tool—it is an evolving methodology, with the measurement of both cortisol and cortisone increasingly representing best practice.

★★★★★ 4.8 · 1,247 reviews

The Adaptogens Your Nervous System Has Been Missing.

Ashwagandha, rhodiola, and phosphatidylserine — clinically-studied ingredients that support healthy cortisol rhythms.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Late-Night vs. Morning Testing: Timing Changes Everything

The timing of a saliva cortisol test is not a minor procedural detail—it fundamentally changes what the test can and cannot detect.

Late-Night Salivary Cortisol (LNSC)

Late-night collection capitalizes on the circadian nadir. Because health y individuals have very low cortisol between 11 p.m. and midnight, even modestly elevated levels at this time are diagnostically significant for autonomous hypersecretion. The test is ideally suited for Cushing's syndrome screening and has strong supporting evidence for that purpose.

Practically, late-night collection at home is an advantage. Patients collect saliva just before sleep, eliminating the stress-related cortisol elevation that can occur with clinic visits or hospital stays. This is particularly important because elevated cortisol due to acute illness or psychological stress—so-called pseudo-Cushing's—can mimic Cushing's syndrome and remains a diagnostic challenge regardless of which assay platform is used.

Morning Testing and the HPA Axis Awakening Response

The morning, particularly the 30-to-45 minute window after waking (the cortisol awakening response, or CAR), represents the daily peak of cortisol secretion. A diminished or absent CAR is one of the features associated with adrenal insufficiency and HPA axis suppression.

Morning salivary cortisol and cortisone measurements are therefore relevant for different clinical questions than late-night samples. A clinician investigating suspected adrenal insufficiency should not apply LNSC protocols; they should collect samples at wake, with post-ACTH stimulation comparison when possible.

The 2025 home waking salivary cortisone study found an AUC of 0.95 (95% CI, 0.92 to 0.97) for adrenal insufficiency, with 70% agreement with ACTH stimulation test data—a strong performance indicator that positions morning home collection as a clinically meaningful tool for this indication as well.

Summary of Timing Recommendations

| Clinical Question | Optimal Timing | Key Biomarker | |---|---|---| | Cushing's screening | Late night (11 p.m.–midnight) | Cortisol + Cortisone | | Adrenal insufficiency | Waking (immediately after wake) | Cortisone, Cortisol | | HPA suppression monitoring | Multiple time points | Both | | ACTH stimulation equivalent | Pre- and post-stimulation | Cortisol |

Salivary Cortisol for Adrenal Insufficiency

Adrenal insufficiency (AI) is a life-threatening condition characterized by inadequate cortisol production. Traditional diagnosis relies on dynamic testing—specifically the ACTH stimulation (Synacthen) test, which requires intravenous or intramuscular ACTH administration followed by timed blood sampling. This is inconvenient, time-limited to clinical settings, and costly.

The question of whether salivary cortisol reliability holds for adrenal insufficiency has therefore attracted significant research interest. The stakes are high: a missed diagnosis can be fatal; an over-diagnosis leads to unnecessary glucocorticoid replacement with its own long-term risks.

ACTH Stimulation and Saliva: Agreement Data

A 2024 study addressed this directly. It examined salivary cortisol response to ACTH stimulation in patients with altered steroid hormone-binding globulin (SHBG) levels—a population where serum total cortisol measurements are notoriously unreliable. The study found 79% overall diagnostic agreement between salivary and serum cortisol responses to ACTH, and concluded that salivary cortisol was a reliable alternative in that specific clinical context.

Seventy-nine percent agreement is encouraging but not perfect. The discordant cases—roughly one in five patients—represent the population in whom clinicians would need to weigh additional testing or use clinical judgment. In practice, this means salivary cortisol can supplement but not yet fully replace formal ACTH stimulation testing in all circumstances.

Home Waking Salivary Cortisone

The more exciting development for adrenal insufficiency diagnosis is the home waking salivary cortisone test, with the landmark 2025 study reporting an AUC of 0.95 against a reference standard of ACTH stimulation. An AUC of 0.95 approaches the performance levels seen in many established laboratory diagnostics and represents a meaningful step toward a home-based diagnostic pathway.

The same study found 70% agreement with ACTH stimulation test data—which, interpreted alongside the AUC, suggests that the test has very high discriminative ability between AI and non-AI, even if individual value-to-value correspondence is not perfect.

This is an important distinction. High AUC with moderate point-agreement means the test is good at correctly classifying most patients (high or low probability of AI) but may show numeric divergence in borderline cases. That is precisely the profile needed for a triage or rule-out test.

2025 Validation Work

A separate 2025 validation study reported that salivary cortisone, cortisol, and dexamethasone all showed strong correlations with standard venipuncture measurements after dexamethasone suppression testing (DST) and ACTH (Cosyntropin) stimulation testing (CST). This multi-analyte approach strengthens confidence that the saliva matrix can support a full picture of HPA axis function—not just a single data point.

Salivary Cortisol vs. Serum and Urine Cortisol

Clinicians evaluating HPA axis disorders typically have three first-line test options: late-night salivary cortisol, 24-hour urinary free cortisol (UFC), and the 1-mg overnight dexamethasone suppression test (ONDST). Understanding where each tool fits requires understanding what each actually measures.

What Each Test Measures

Serum cortisol measures total cortisol (bound + free), making it sensitive to changes in CBG. It captures a single-moment snapshot, which is useful in dynamic testing contexts (ACTH stimulation, insulin tolerance test) but limited for the circadian pattern assessment that matters in Cushing's evaluation.

24-hour urinary free cortisol integrates free cortisol excretion over an entire day, capturing integrated free cortisol burden. It is less sensitive to acute fluctuations but requires a complete 24-hour collection, which many patients find difficult to perform accurately.

Salivary cortisol measures free cortisol at a specific time point, is unaffected by CBG, and can be collected at times (late night) that are not feasible for blood draws in most settings. Multiple samples can be collected across a day without clinical assistance.

Comparative Accuracy

For Cushing's syndrome screening, meta-analyses have generally found all three tests to perform comparably when used according to protocol, with some studies favoring LNSC for sensitivity and ONDST for specificity. The salivary cortisol clinical performance advantage becomes most pronounced in:

• Patients with altered CBG (oral contraceptive use, pregnancy, liver disease)
• Patients who cannot attend fasted morning clinic appointments
• Children and adolescents (for whom repeated venipuncture is distressing)
• Outpatient population-level screening research

For adrenal insufficiency, serum cortisol measured at 30 and 60 minutes post-ACTH stimulation remains the reference standard, but as discussed, salivary cortisone is emerging as a strong home-based alternative.

Salivary Cortisol vs. Salivary Cortisone: A Critical Distinction

One of the most clinically significant developments in recent saliva cortisol research is the recognition that salivary cortisone—not just salivary cortisol—deserves independent diagnostic consideration.

As noted earlier, the enzyme 11β-HSD2 in salivary glands converts cortisol to cortisone locally. In most individuals, salivary cortisone concentrations are higher than salivary cortisol concentrations. This means that if you measure only cortisol in saliva, you are capturing a fraction of the total glucocorticoid signal passing through the salivary glands.

Why Cortisone May Be More Informative

Because cortisone is not bound by CBG—and because cortisol-to-cortisone conversion in the salivary gland is a fairly consistent enzymatic process—salivary cortisone may actually be a more stable and less contamination-sensitive measure of HPA axis activity than salivary cortisol in some contexts.

Immunoassay methods for salivary cortisol often show cross-reactivity with cortisone, which historically meant that cortisone contributed to the measured cortisol signal without being separated. With LC-MS/MS methods, cortisol and cortisone can be measured simultaneously and precisely, enabling a more complete picture.

The 2025 study on morning salivary cortisone for suspected Cushing's syndrome achieved 100% sensitivity using cortisone rather than cortisol as the primary analyte—a performance figure that, if replicated, would be clinically significant. Similarly, the 2025 waking salivary cortisone work (AUC 0.95 for adrenal insufficiency) used cortisone as the key biomarker.

The emerging consensus in the field is that clinical protocols should ideally report both salivary cortisol and salivary cortisone, particularly when LC-MS/MS is available. Using only one analyte leaves diagnostic information on the table.

Immunoassay vs. LC-MS/MS: Which Method Is More Reliable?

The cortisol saliva accuracy question cannot be answered without addressing the analytical method used to measure it. There are two main platforms: immunoassay and liquid chromatography–tandem mass spectrometry (LC-MS/MS).

Immunoassay

Immunoassay methods—including enzyme-linked immunosorbent assay (ELISA), chemiluminescent immunoassay (CLIA), and radioimmunoassay (RIA)—use antibody-antigen binding to quantify cortisol. They are:

• Widely available
• Lower cost per sample
• Faster throughput
• Suitable for high-volume clinical laboratories

However, immunoassays carry meaningful limitations for salivary cortisol:

Cross-reactivity. Antibodies raised against cortisol may also recognize structurally similar molecules, including cortisone, prednisolone, prednisone, cortisol metabolites, and other endogenous steroids. This inflates measured cortisol values in some patients.

Matrix interference. Salivary matrix components—mucins, enzymes, pH variation—can interfere with antibody binding in ways that serum-calibrated assays do not account for.

Inter-assay variability. Reference ranges established with one immunoassay kit are not reliably transferable to another. A patient classified as abnormal by one assay might be classified as normal by another.

LC-MS/MS

Liquid chromatography–tandem mass spectrometry separates compounds by their molecular mass and fragmentation patterns, offering near-absolute specificity. For salivary cortisol:

• Simultaneously measures cortisol and cortisone
• Eliminates cross-reactivity issues
• Can measure dexamethasone directly (relevant for DST interpretation)
• Provides results in absolute concentration terms independent of antibody batch variability

The trade-offs are cost, equipment requirements, and specialized technical expertise. LC-MS/MS is not universally available, particularly outside academic medical centers.

The Practical Implication

When reviewing published studies on salivary cortisol reliability, the assay method used is a critical variable. A study using RIA published in 2002 is not directly comparable to a study using LC-MS/MS published in 2024. The 2025 validation study confirming strong correlations between salivary and serum measurements after DST and CST used LC-MS/MS methodology—which is part of why its findings carry weight.

For clinical practice, using LC-MS/MS when available, and being cautious about applying immunoassay-derived reference ranges to LC-MS/MS results (or vice versa), is the current evidence-based position.

What Causes False Positives and False Negatives?

Understanding the failure modes of any diagnostic test is as important as understanding its strengths. Salivary cortisol validity is real, but it is bounded by sources of error that are largely avoidable if understood.

False Positives (Elevated Salivary Cortisol in Non-Cushing's Individuals)

Blood contamination. Gum disease, recent dental work, mucosal trauma from aggressive brushing, or lip chapping can introduce serum cortisol directly into the sample. Because serum total cortisol is far higher than salivary free cortisol, even small amounts of blood contamination can substantially elevate the measured value. Patients should be instructed to avoid tooth brushing, flossing, or anything causing oral bleeding for at least 30 minutes before collection.

Acute psychological stress. The HPA axis responds to stress within minutes. Hospital admission, acute illness, or significant emotional distress can elevate cortisol levels even at night. This is the mechanism behind pseudo-Cushing's syndrome—a condition in which patients with depression, anxiety, alcoholism, or obesity can present with elevated salivary cortisol that resembles true hypercortisolism.

Exogenous cortisol or cortisone. Topical corticosteroids applied near the face, inhaled corticosteroids, or any glucocorticoid formulation can contribute to salivary measurements depending on route and dosage.

Immunoassay cross-reactivity. As discussed above, structurally similar steroids can inflate immunoassay-based cortisol readings.

False Negatives (Low Salivary Cortisol Despite Pathology)

Cyclic Cushing's syndrome. Some patients with Cushing's have episodic cortisol secretion. A sample collected during a quiescent phase may appear normal. This is why guidelines recommend collection on multiple separate nights before concluding a normal result.

ACTH-independent Cushing's syndrome. The 2020 data showing only 31.3% sensitivity for this subtype with EIA-F illustrates that certain forms of Cushing's—particularly adrenal adenomas secreting cortisol intermittently or at levels just above normal—can be missed by LNSC testing.

Incorrect collection timing. A sample collected at 9 p.m. instead of 11 p.m. may not capture the true nadir; conversely, a morning sample compared against late-night reference ranges will produce a meaninglessly high value.

Salivary gland dysfunction. Conditions affecting salivary gland output (Sjögren's syndrome, radiation sialadenitis, anticholinergic medications) can alter the concentration and composition of saliva in ways that affect cortisol measurement.

What 2024–2025 Research Adds to the Picture

The most current saliva cortisol research paints a picture of a maturing field—one that is moving from validation of the basic concept toward refinement of protocols, populations, and analytes.

ACTH Stimulation in Altered CBG Patients (2024)

The 2024 study confirming 79% diagnostic agreement between salivary and serum cortisol responses to ACTH stimulation is clinically useful because it targets a specific gap: patients in whom serum total cortisol is unreliable due to CBG abnormalities. For this population, the saliva matrix is not just a convenience—it may actually be a more physiologically accurate measure than serum total cortisol. The study concluded that the cortisol saliva test is a reliable alternative in this context, with the caveat that the 21% discordance warrants continued clinical vigilance.

Morning Salivary Cortisone for Cushing's Screening (2025)

The 2025 finding of 100% sensitivity for morning salivary cortisone in ONDST-based Cushing's evaluation is a notable result. In screening contexts, sensitivity is the priority—missing a case of Cushing's syndrome carries greater harm than a false positive that triggers further testing. If the 100% sensitivity finding is replicated in independent cohorts, it could support morning salivary cortisone as a screening option that does not require the logistical challenge of midnight sample collection.

Home Waking Salivary Cortisone for Adrenal Insufficiency (2025)

An AUC of 0.95 for adrenal insufficiency is a strong diagnostic performance figure. For context, AUC values above 0.90 are generally considered excellent diagnostic accuracy. The 70% agreement with ACTH stimulation data positions home waking cortisone not as a replacement for formal testing in all patients, but as a potentially powerful triage tool that could identify which patients need urgent ACTH stimulation testing and which can be safely monitored.

The home-based nature of the protocol is particularly significant for patients with suspected secondary adrenal insufficiency following pituitary surgery, long-term glucocorticoid therapy, or immunotherapy—populations who may have difficulty attending repeated clinic-based stimulation tests.

Multi-Analyte Validation (2025)

The 2025 validation study demonstrating strong correlation between salivary cortisone, cortisol, and dexamethasone with venipuncture equivalents after DST and CST represents the kind of rigorous methodological work the field needs. When salivary measurements of three distinct analytes all correlate well with gold-standard measurements simultaneously, it strengthens confidence that the saliva matrix is reliable as a platform—not just for a single compound under ideal conditions.

★★★★★ 4.8 · 1,247 reviews

See Why Athletes And Executives Take It Daily.

Adaptogen-based formula, third-party tested, made in the USA. Cancel subscription anytime.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Practical Guidance for Clinicians and Patients

Based on the evidence reviewed, the following practical points reflect current best understanding of salivary cortisol clinical use:

For Clinicians

1. Use LNSC as a front-line test for Cushing's screening. Multiple measurements (ideally two separate nights) should be obtained before confirming abnormality. The 2002 foundational data and subsequent confirmatory studies support this approach, and current Endocrine Society guidelines endorse it.

2. Recognize subtype-specific sensitivity limitations. The 2020 data showing only 31.3% sensitivity for ACTH-independent Cushing's syndrome means LNSC should not be used in isolation when this subtype is strongly suspected. Combine with UFC or ONDST.

3. Specify assay methodology on requisition forms and in clinical notes. Results from immunoassay and LC-MS/MS are not interchangeable. Reference ranges differ; case definitions differ. When possible, LC-MS/MS with simultaneous cortisol and cortisone measurement is the preferred analytical approach.

4. Consider salivary cortisone alongside or instead of cortisol. Particularly for adrenal insufficiency evaluation and Cushing's screening in patients where CBG abnormality is suspected, salivary cortisone adds diagnostic value.

5. Educate patients on collection protocol. Blood contamination from oral mucosal injury is the single most preventable source of false positive results. Clear written instructions—no brushing, no flossing, no eating, no acidic beverages for 30–60 minutes before collection—should be provided.

6. Be cautious about pseudo-Cushing's. Patients with depression, alcoholism, obesity, or acute illness can present with elevated LNSC that does not reflect true autonomous hypercortisolism. Late-night plasma ACTH, CRH stimulation testing, or dexamethasone-CRH testing may be needed for differentiation.

For Patients

• Follow the collection instructions provided by your healthcare team precisely—timing and preparation matter more than you might expect.
• Collect on at least two separate evenings if your clinician requests late-night samples; a single elevated result is not a diagnosis.
• Inform your provider of any medications, particularly topical, inhaled, or oral corticosteroids, as these can affect results.
• If you have gum disease or recent dental work, notify your provider, as this can cause false elevations.
• Store samples according to the laboratory's instructions; salivary cortisol is generally stable refrigerated or frozen, but exposure to prolonged heat before processing can degrade the sample.

Frequently Asked Questions

Is salivary cortisol clinically valid for diagnosing Cushing's syndrome?

Yes, with important caveats. Late-night salivary cortisol testing has demonstrated sensitivity up to 93% in well-characterized cohorts, and the addition of salivary cortisone measurement has shown even stronger performance in recent studies. However, sensitivity varies by Cushing's subtype—ACTH-independent forms show lower detection rates—and results should always be confirmed with at least two measurements and often with complementary testing.

How does salivary cortisol compare with serum cortisol and 24-hour urine cortisol?

Each test serves a different purpose. Salivary cortisol measures the free, biologically active fraction at a single time point and is unaffected by CBG levels. Serum total cortisol captures bound plus free cortisol and is CBG-sensitive. Twenty-four-hour urinary free cortisol integrates free cortisol excretion across an entire day. For Cushing's screening, all three are guideline-endorsed first-line options with broadly comparable performance. Salivary cortisol has a logistical advantage for late-night sampling and in CBG-altered patients.

Is salivary cortisol reliable for adrenal insufficiency testing?

Emerging data are encouraging. Waking salivary cortisone showed an AUC of 0.95 for adrenal insufficiency in a 2025 study, and 2024 data confirmed 79% agreement between salivary and serum cortisol responses to ACTH stimulation. Salivary testing is not yet a full replacement for the ACTH stimulation test in all settings, but it is developing as a strong triage and monitoring tool.

What is the difference between salivary cortisol and salivary cortisone?

Cortisol is the active glucocorticoid; cortisone is its inactive metabolite. Salivary glands convert cortisol to cortisone via the enzyme 11β-HSD2, meaning both compounds are present in saliva—with cortisone often present at higher concentrations. LC-MS/MS can measure both simultaneously. Recent research suggests salivary cortisone may be as or more diagnostically informative than cortisol in some clinical contexts.

When should saliva samples be collected for the most accurate result?

For Cushing's syndrome screening: between 11 p.m. and midnight (late-night collection). For adrenal insufficiency evaluation: immediately upon waking, ideally before rising from bed. The clinical question determines the correct collection time; applying the wrong protocol to the wrong question produces unreliable results.

Do immunoassay and LC-MS/MS methods give the same answers?

No, not reliably. Immunoassays can cross-react with cortisone and other steroids, tend to measure higher absolute values than LC-MS/MS, and have reference ranges that are assay-specific. LC-MS/MS provides greater specificity and can measure multiple analytes simultaneously. Reference ranges and cutoff values must be matched to the assay method being used.

What causes false positives in salivary cortisol testing?

The most common causes are blood contamination from oral mucosal injury, acute psychological stress or illness, exogenous steroid exposure, and immunoassay cross-reactivity with cortisone or other steroids.

What causes false negatives?

Cyclic Cushing's syndrome (episodic secretion), ACTH-independent Cushing's with modest hypercortisolism, incorrect collection timing, and salivary gland dysfunction are the main contributors to false negative results.

Is late-night salivary cortisol more useful than morning testing?

For Cushing's syndrome: yes. For adrenal insufficiency: morning waking cortisone is more appropriate. The tests address different physiological questions tied to the circadian cortisol rhythm, and neither timing is inherently superior—they are complementary tools for different clinical indications.

Conclusion

The evidence base for salivary cortisol testing clinical validity has grown substantially and continues to evolve. What began as a promising non-invasive alternative to venipuncture has matured into a clinically supported methodology with well-defined strengths, measurable limitations, and an expanding range of applications.

Salivary cortisol validity for Cushing's syndrome screening is well-established, particularly for ACTH-dependent hypercortisolism, with foundational sensitivity data from 2002 reinforced and refined through more than two decades of subsequent study. Salivary cortisol reliability for adrenal insufficiency evaluation is newer but increasingly compelling, with 2024 and 2025 data providing AUC values and agreement rates that approach clinical threshold.

Several themes emerge as constant across the evidence:

• Timing matters enormously and must match the clinical question
• Salivary cortisone deserves equal attention to salivary cortisol
• LC-MS/MS outperforms immunoassay in specificity and multi-analyte capability
• Blood contamination and immunoassay cross-reactivity remain the most common sources of error
• Single measurements are rarely sufficient; protocols requiring two or more samples exist for good reason

The salivary cortisol biomarker is not a replacement for all conventional HPA axis testing, but it is a legitimate, scientifically grounded tool that offers real clinical value—particularly for late-night Cushing's screening and as an emerging home-based option for adrenal insufficiency triage. As LC-MS/MS becomes more accessible and the evidence base for salivary cortisone continues to strengthen, the role of saliva-based HPA assessment in routine clinical practice is likely to expand further.

★★★★★ 4.8 · 1,247 reviews

Ready To Try Adaptogen-Based Cortisol Support?

Third-party tested. 60-day guarantee. Free shipping over $40. Ships in 24 hours.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

This content is intended for educational and informational purposes. It does not constitute medical advice. Clinical decisions regarding cortisol testing should be made in consultation with a qualified healthcare provider, guided by current endocrine society guidelines and the specific clinical context of the individual patient.

References:

1. PMC Article PMC10527706. National Library of Medicine. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10527706/
2. Journal of Clinical Endocrinology & Metabolism, 109(2):e579. Oxford Academic. Available at: https://academic.oup.com/jcem/article/109/2/e579/7285263
3. PMC Article PMC12134430. National Library of Medicine. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12134430/
4. Raff H, et al. Late-night salivary cortisol for the diagnosis of Cushing's syndrome: a meta-analysis. Endocr Pract. 2002.
5. Retrospective cohort study: EIA-F sensitivity analysis for hypercortisolism subtypes, 2020.
6. ACTH stimulation salivary cortisol agreement study in CBG-altered patients, 2024.
7. Morning salivary cortisone vs. serum cortisol in ONDST Cushing's evaluation, 2025.
8. Home waking salivary cortisone for adrenal insufficiency: AUC 0.95 study, 2025.
9. Salivary cortisone, cortisol, dexamethasone validation after DST and CST, 2025.